Cipta Sarana Medika Tbk. vs Trimegah Bangun Persada Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 24.02M 24h volume), while Trimegah Bangun Persada Tbk. trades at Rp840 (market cap 52.69T, 53.38M 24h volume). The key difference: Trimegah Bangun Persada Tbk. is far larger — about 327.9× Cipta Sarana Medika Tbk.'s market cap, and Trimegah Bangun Persada Tbk. is more actively traded (53.38M versus 24.02M). Which is the better fit depends on your goals.
| DKHH | NCKL | |
|---|---|---|
Market Cap | 160.67B | 52.69T |
Volume | 24.02M | 53.38M |
Lot | 240.19K | 533.77K |
Turnover | 1.56B | 45.04B |
Average Price | 65 | 843.75 |
Value | 1.56B | 45.04B |
Indicative Equilibrium Price | 64 | 840 |
Indicative Equilibrium Volume | 1.67K | 63.41K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Trimegah Bangun Persada Tbk. (the Company) was established in Indonesia based on Notarial Deed of Erna Priyono, S.H., No. 03 dated September 6, 2004.
Read more on NCKL →